Article
Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.
Parkinsonism & related disorders - 1 Feb 2013
Barrett M J, Hagenah J, Dhawan V, Peng S, Stanley K, Raymond D, Deik A, Gross S J, Schreiber-Agus N, Mirelman A, Marder K, Ozelius L J, Eidelberg D, Bressman S B, Saunders-Pullman R
Abstract excerpt
BACKGROUND: Heterozygous glucocerebrosidase (GBA) mutations are the leading genetic risk factor for Parkinson disease, yet imaging correlates, particularly transcranial sonography, have not been extensively described. METHODS: To determine whether GBA mutation heterozygotes with Parkinson disease demonstrate hyperechogenicity of the substantia nigra, transcranial sonography was performed in Ashkenazi Jewish...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
